This study is testing a device called the Cervical Collar Therapy Indicator (CoTI) for people with thyroid cancer or Graves' disease. The CoTI is a collar worn around the neck that continuously measures radiation exposure during radioiodine treatment. Researchers believe this device will provide more accurate estimates of radiation exposure to thyroid tissue compared to current methods. The goal is to help doctors give the best possible dose of radioiodine to each patient, potentially reducing side effects and improving treatment success. The study will evaluate how much the radioiodine levels vary in patients over 6-9 months. You may be able to join if you are between 21 and 65 years old, understand English, and have either Graves' disease or certain types of thyroid cancer requiring radioiodine treatment. The current status of the study is unclear.

Study design

This is an interventional study with a planned enrollment of 10 participants. It is not specified if it is randomized or blinded.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will evaluate radioiodine kinetics for patients over 6-9 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.